This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Mar;245(3):353-4.

doi: 10.1097/01.sla.0000256393.24245.fc.

Effective neoadjuvant therapy prior to metastasectomy: a new paradigm

Richard D Schulick

PMID: 17435540
PMCID: PMC1877025
DOI: 10.1097/01.sla.0000256393.24245.fc

Editorial

Effective neoadjuvant therapy prior to metastasectomy: a new paradigm

Richard D Schulick. Ann Surg. 2007 Mar.

. 2007 Mar;245(3):353-4.

doi: 10.1097/01.sla.0000256393.24245.fc.

Author

Richard D Schulick

PMID: 17435540
PMCID: PMC1877025
DOI: 10.1097/01.sla.0000256393.24245.fc

No abstract available

PubMed Disclaimer

Comment on

Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.
Gronchi A, Fiore M, Miselli F, Lagonigro MS, Coco P, Messina A, Pilotti S, Casali PG. Gronchi A, et al. Ann Surg. 2007 Mar;245(3):341-6. doi: 10.1097/01.sla.0000242710.36384.1b. Ann Surg. 2007. PMID: 17435538 Free PMC article.
Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor.
DeMatteo RP, Maki RG, Singer S, Gonen M, Brennan MF, Antonescu CR. DeMatteo RP, et al. Ann Surg. 2007 Mar;245(3):347-52. doi: 10.1097/01.sla.0000236630.93587.59. Ann Surg. 2007. PMID: 17435539 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources